Table 3: Therapeutic effects of Graptopetalum paraguayense (GP) on DMN-induced liver fibrosis in rats via biochemical analysis (2).

Numeric variable p a Categorical variableb Drugc Weekd Drug × Week 1st to 2nd wk 3rd to 4th wk 5th to 6th wk Albumin 0.1285 0.3895 0.2342 −0.17 0.38 0.83 GPT 0.0003 0.6769 0.7826 −225 −360 −501 GOT <0.0001 0.3298 0.2164 −390 −816 −1355 Bilirubin <0.0001 0.6728 0.7539 −0.48 −0.75 −1 AKP <0.0001 0.6172 0.1147 −303 −230 −107 LDH <0.0001 0.0132 0.0013 −63 −141 −363 Globulin 0.1341 0.029 0.0254 −0.75 0.58 1.65 Triglyceride 0.0658 0.4116 0.355 −78 −84 −5 AFP 0.0031 0.8992 0.6289 −0.2 −0.1 −0.1 CHOL 0.324 0.9847 0.3248 −16.5 −3.6 4.2 BUN 0.0444 0.5896 0.4293 −13.8 −13.6 −1.6 ACP 0.097 0.0004 0.0006 1.8 −0.7 −3.6 PT 0.0285 0.7278 0.9627 −2.4 −2.5 −5.3 PLT 0.0008 0.3879 0.4526 129 249 476

a: Significant correction is marked in bold at the 0.05 level by two-way ANOVA. b: AverageDMN + GP-AverageDMN in 1st to 2nd, 3rd to 4th or 5th to 6th week. c: DMN or DMN + GP treatment groups. d: 1st to 2nd, 3rd to 4th or 5th to 6th week.